Login Register Cart 0
Generic placeholder image

Current HIV Research

Editor-in-Chief

ISSN (Print): 1570-162X
ISSN (Online): 1873-4251

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Prevalence of Erectile Dysfunction (ED) among People Living with HIV in Tehran, Iran

Author(s): SeyedAli Dehghan Manshadi, Ali Keyhani Pirdehi, Elnaz Shahmohamadi, Malihe Hasan Nezhad, Faezeh Abbaspour, Sona Mahrokhi and SeyedAhmad SeyedAlinaghi*

Volume 21, Issue 6, 2023

Published on: 06 December, 2023

Page: [361 - 366] Pages: 6

DOI: 10.2174/011570162X270146231205105957

Price: $65

Abstract

Background: Sexual problems are rarely addressed in human immunodeficiency virus (HIV) management, even though overt sexual dysfunctions are more prevalent in people living with HIV. This study aimed to ascertain the prevalence of erectile dysfunction (ED) among HIVinfected men in a stable clinical state, examine the relationship between antiretroviral therapy (ART) exposure and sexual dysfunction, and identify the associated risk factors.

Method: This cross-sectional study recruited HIV-positive males who visited the Voluntary Counseling and Testing (VCT) center of Imam Khomeini Hospital (Tehran) in 2020. The International Index of Erectile Function (IIEF) questionnaire was used to evaluate the ED in participants. Sociodemographic and clinical data were also collected.

Results: Of 65 patients who participated in this study, 27.7% had ED. The mean age of participants with and without ED was 39.4±11.5 and 40.4±7.6 years old, respectively. No significant difference was observed between patients with and without ED concerning the sociodemographic status and the use of ART drugs.

Conclusion: The prevalence of ED is relatively high among men living with HIV. Future research is recommended among HIV-positive males to identify the underlying causes and explore the potential impact that associated psychological distress could have on sexual dysfunction.

Keywords: Antiretroviral therapy, erectile dysfunction, HIV, prevalence, risk factors, sexual dysfunction.

« Previous Next »
[1]
Mohraz M, Dejman M, Ardakani HM, et al. Psychological, social, and familial problems of people living with HIV/AIDS in Iran: A qualitative study. Int J Prev Med 2015; 6(1): 126.
[http://dx.doi.org/10.4103/2008-7802.172540] [PMID: 26900440]
[2]
Scanavino MT. Sexual dysfunctions of hiv-positive men: Associated factors, pathophysiology issues, and clinical management. Adv Urol 2011; 2011: 1-10.
[http://dx.doi.org/10.1155/2011/854792] [PMID: 22046183]
[3]
Crum-Cianflone NF, Bavaro M, Hale B, et al. Erectile dysfunction and hypogonadism among men with HIV. AIDS Patient Care STDS 2007; 21(1): 9-19.
[http://dx.doi.org/10.1089/apc.2006.0071] [PMID: 17263654]
[4]
Yafi FA, Jenkins L, Albersen M, et al. Erectile dysfunction. Nat Rev Dis Primers 2016; 2(1): 16003.
[http://dx.doi.org/10.1038/nrdp.2016.3] [PMID: 27188339]
[5]
Crum NF, Furtek KJ, Olson PE, Amling CL, Wallace MR. A review of hypogonadism and erectile dysfunction among HIV-infected men during the pre- and post-HAART eras: diagnosis, pathogenesis, and management. AIDS Patient Care STDS 2005; 19(10): 655-71.
[http://dx.doi.org/10.1089/apc.2005.19.655] [PMID: 16232050]
[6]
Rasoolinejad M, Asadollahi–Amin A, Dadras O, Pourdast A, Ghavam S, SeyedAlinaghi S, Jafari M, Hasannejad M, Moradmand-Badie B. The effect of first- and second-line antiretroviral therapies on lipid profile of HIV/AIDS patients. J Iranian Med Council 2020; 3(4): 193-199.
[http://dx.doi.org/10.18502/jimc.v3i4.5190]
[7]
Collazos J. Sexual dysfunction in the highly active antiretroviral therapy era. AIDS Rev 2007; 9(4): 237-45.
[PMID: 18219367]
[8]
Luo L, Deng T, Zhao S, Li E, Liu L, Li F, et al. Association between HIV infection and prevalence of erectile dysfunction: A systematic review and meta-analysis 2017; 14(9): 1125-32.
[http://dx.doi.org/10.1016/j.jsxm.2017.07.001]
[9]
Colson AE, Keller MJ, Sax PE, Pettus PT, Platt R, Choo PW. Male sexual dysfunction associated with antiretroviral therapy. J Acquir Immune Defic Syndr 2002; 30(1): 27-32.
[http://dx.doi.org/10.1097/00042560-200205010-00004] [PMID: 12048360]
[10]
Rhoden EL, Telöken C, Sogari PR, Vargas Souto CA. The use of the simplified International Index of Erectile Function (IIEF-5) as a diagnostic tool to study the prevalence of erectile dysfunction. Int J Impot Res 2002; 14(4): 245-50.
[http://dx.doi.org/10.1038/sj.ijir.3900859] [PMID: 12152112]
[11]
De Vincentis S, Tartaro G, Rochira V, Santi D. HIV and sexual dysfunction in men. J Clin Med 2021; 10(5): 1088.
[http://dx.doi.org/10.3390/jcm10051088] [PMID: 33807833]
[12]
Dadgar F, Moshfeghy Z, Janghorban R, Doostfatemeh M. Predictors of sexual dysfunction in HIV-infected men. Acta facultatis medicae Naissensis 2022; 39(3): 338-46.
[13]
Luo L, Deng T, Zhao S, et al. Association between HIV infection and prevalence of erectile dysfunction: A systematic review and meta-analysis. J Sex Med 2017; 14(9): 1125-32.
[http://dx.doi.org/10.1016/j.jsxm.2017.07.001] [PMID: 28778576]
[14]
Zona S, Guaraldi G, Luzi K, et al. Erectile dysfunction is more common in young to middle-aged HIV-infected men than in HIV-uninfected men. J Sex Med 2012; 9(7): 1923-30.
[http://dx.doi.org/10.1111/j.1743-6109.2012.02750.x] [PMID: 22548701]
[15]
Mbwambo OJ, Lyatuu M, Ngocho G, Abdallah K, Godfrey P, Ngowi BN, et al. The high burden of erectile dysfunction among men living with HIV in northern Tanzania: A call for evidence-based interventions. Frontiers in Urology 2023; 3
[http://dx.doi.org/10.3389/fruro.2023.1238293]
[16]
Huntingdon B, Muscat DM, de Wit J, Duracinsky M, Juraskova I. Factors associated with erectile dysfunction among men living with HIV: A systematic review. AIDS Care 2020; 32(3): 275-85.
[http://dx.doi.org/10.1080/09540121.2019.1653443] [PMID: 31394923]
[17]
Lewis RW, Fugl-Meyer KS, Corona G, et al. Definitions/epidemiology/risk factors for sexual dysfunction. J Sex Med 2010; 7(4): 1598-607.
[http://dx.doi.org/10.1111/j.1743-6109.2010.01778.x] [PMID: 20388160]
[18]
Santi D, Brigante G, Zona S, Guaraldi G, Rochira V. Male sexual dysfunction and HIV-a clinical perspective. Nat Rev Urol 2014; 11(2): 99-109.
[http://dx.doi.org/10.1038/nrurol.2013.314] [PMID: 24394405]
[19]
Asboe D, Catalan J, Mandalia S, et al. Sexual dysfunction in HIV-positive men is multi-factorial: A study of prevalence and associated factors. AIDS Care 2007; 19(8): 955-65.
[http://dx.doi.org/10.1080/09540120701209847] [PMID: 17851990]
[20]
Moreno-Pérez O, Escoín C, Serna-Candel C, et al. Risk factors for sexual and erectile dysfunction in HIV-infected men: The role of protease inhibitors. AIDS 2010; 24(2): 255-64.
[http://dx.doi.org/10.1097/QAD.0b013e328334444b] [PMID: 19915446]
[21]
Albert DC, Adébayo A, Angelo AC, Ibrahim MC, Khadidjatou SA. Frequency and factors associated with erectile dysfunction in people living with hiv managed in the department of internal medicine at the departmental hospital university of borgou (DHU-B) in 2017. Open Journal of Internal Medicine 2022; 12(2): 112-20.
[http://dx.doi.org/10.4236/ojim.2022.122013]
[22]
Fumaz CR, Ayestaran A, Perez-Alvarez N, Muñoz-Moreno JA, Ferrer MJ, Negredo E, et al. Clinical and emotional factors related to erectile dysfunction in HIV-infected men 2017; 11(3): 647-53.
[http://dx.doi.org/10.1177/1557988316669041]
[23]
Gomes TV, Brites C. Prevalence and risk factors for erectile dysfunction in HIV-infected patients in Salvador, Brazil. Braz J Infect Dis 2019; 23(6): 464-7.
[http://dx.doi.org/10.1016/j.bjid.2019.08.006] [PMID: 31545951]
[24]
Dupras ANDRÉ, Morisset R. Sexual dysfunction among HIV-positive gay males. Sex Marital Ther 1993; 8(1): 37-46.
[http://dx.doi.org/10.1080/02674659308404499]
[25]
Schrooten W, Colebunders R, Youle M, et al. Sexual dysfunction associated with protease inhibitor containing highly active antiretroviral treatment. AIDS 2001; 15(8): 1019-23.
[http://dx.doi.org/10.1097/00002030-200105250-00010] [PMID: 11399984]
[26]
Romero-Velez G, Lisker-Cervantes A, Villeda-Sandoval CI, et al. Erectile dysfunction among HIV patients undergoing highly active antiretroviral therapy: Dyslipidemia as a main risk factor. Sex Med 2014; 2(1): 24-30.
[http://dx.doi.org/10.1002/sm2.25] [PMID: 25356298]
[27]
SeyedAlinaghi S, Jam S, Foroughi M, Imani A, Mohraz M, Djavid GE, Black DS. Randomized controlled trial of mindfulness-based stress reduction delivered to human immunodeficiency virus-positive patients in Iran: effects on CD4+ T lymphocyte count and medical and psychological symptoms. Psychosom Med 2012; 74(6): 620-7.
[http://dx.doi.org/10.1097/PSY.0b013e31825abfaa] [PMID: 22753635]
[28]
Razavi P, Hajifathalian K, Saeidi B, Esmaeeli Djavid G, Rasoulinejad M, Hajiabdolbaghi M, Paydary K, Kheirandish P, Foroughi M, Seyedalinaghi S, Mohraz M, McFarland W. Quality of life among persons with HIV/AIDS in Iran: Internal reliability and validity of an international instrument and associated factors. AIDS Res Treat 2012; 2012: 849406.
[http://dx.doi.org/10.1155/2012/849406] [PMID: 22292116]
[29]
Ghalehkhani N, Farhoudi B, Gouya MM, Sharifi H, SeyedAlinaghi S, Kamali K, Fahimfar N, Rajabpour Z, Doosti-Irani A, Sedaghat A, Mirzazadeh A. The HIV treatment cascade in people living with HIV in Iran in 2014: Mixed-method study to measure losses and reasons. Int J STD AIDS 2019; 30(13): 1257-1264.
[http://dx.doi.org/10.1177/0956462419867573] [PMID: 31558135]
[30]
Ghayomzadeh M, Etesami MS, Earnest CP, Rezaei S, Navalta JW, Taj L, SeyedAlinaghi S, Mohraz M, Gharakhanlou R, Voltarelli FA. Effect of a short-term lifestyle modification program on quality of life, anthropometric characteristics and CD4+T cell count of HIV infected patients in Tehran/Iran: A randomized controlled trial. Explore (NY) 2019; 15(4): 308-315.
[http://dx.doi.org/10.1016/j.explore.2019.01.004] [PMID: 30833130]
[31]
Ghodrati S, Shahabinezhad Z, SeyedAlinaghi S. Association Between Immunologic and Virologic Functioning and Health-Related Quality of Life Among People Living with HIV, Tehran, Iran. Infect Disord Drug Targets 2019; 19(3): 297-303.
[http://dx.doi.org/10.2174/1871526519666181221123932] [PMID: 30574855]
[32]
Rasoolinejad M, Najafi E, Hadadi A, Najafi M, Kalantari S, Moradmand-Badie B, Tayeri K, SeyedAlinaghi S. Prevalence and Associated Risk Factors of Hyperglycemia and Diabetes Mellitus Among HIV Positive Patients in Tehran, Iran. Infect Disord Drug Targets 2019; 19(3): 304-309.
[http://dx.doi.org/10.2174/1871526518666180723152715] [PMID: 30039766]
[33]
Zandmomen Z, Sardashti S, Firouzeh MM, Aminabad FJ, Ghanbariragheb H, SeyedAlinaghi S, Mohraz M. Addressing predictors of HIV related risk behaviors: demographic and psychosocial profile of Iranian patients. J Infect Public Health 2014; 7(6): 472-80.
[http://dx.doi.org/10.1016/j.jiph.2014.07.014] [PMID: 25182509]

Rights & Permissions Print Cite
Article Metrics
15
2
© 2024 Bentham Science Publishers | Privacy Policy